Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-10, Stock:ABBV, The news for the past five days is as follows:
2019-12-03: NEWS1: Where to Buy Booming Biotech ETFs.NEWS2: [video]AbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis Drug.
2019-12-04: nan
2019-12-05: NEWS1: J&J Stock Witnesses Volatility in '19: What to Expect in 2020.
2019-12-06: NEWS1: Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting.NEWS2: Belgium's UCB says psoriasis drug beats AbbVie's Humira in trial.NEWS3: AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis.
2019-12-09: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.NEWS2: World's largest biotech company to move up to BioMed's big South City project.NEWS3: J&J Presents Data on CAR-T Therapy Drug and Imbruvica at ASH.NEWS4: Sanofi to Buy Synthorx for $2.5B to Boost Cancer Portfolio.NEWS5: 3 Top Dividend Stocks to Maximize Your Retirement Income - December 09, 2019.NEWS6: Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay.NEWS7: AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics.

Answer: Rise